论文部分内容阅读
环孢霉素A(cyclosporin A)系瑞士Sandoz公司科学家报道的一种免疫抑制剂。它在动物实验性器官移植中能显著地延长移植物的存活时间;临床试用于肝、肾、心、肺、胰腺、骨髓等。业已证明,对器官移植排异有较好抑制效果,其免疫抑制作用优于现有的任何免疫抑制剂,它选择性地抑制T淋巴细胞的某些亚群,而对骨髓无抑制作用,可有效地防治移植物抗宿主反应的发生,是目前国外器官移植所试用的第三代新的免疫
Cyclosporin A (cyclosporin A) is an immunosuppressant reported by scientists from Sandoz, Switzerland. It can significantly prolong graft survival in animal experimental organ transplantation; clinical trial for liver, kidney, heart, lung, pancreas, bone marrow and so on. It has been demonstrated that organ transplant rejection has a better inhibitory effect, its immunosuppressive effect is superior to any existing immunosuppressive agents, it selectively inhibits certain subpopulations of T lymphocytes, but no inhibition of the bone marrow can be Effective prevention and treatment of graft versus host reaction is the third generation of new immunity